⬡   Every batch third-party tested — view the COA library

GLP-3/R 50mg

$175.00

GLP-3/R is a next-generation metabolic peptide designed as a triple-agonist for the GLP-1, GIP, and glucagon receptors. Each vial contains 50mg — our highest concentration option for extended research protocols.

BUY 5 save 5%

BUY 10 save 10%

In stock

Description

Mechanism of Action:

  • GLP-1 agonist → enhanced glucose-dependent insulin release, slower gastric emptying, and reduced appetite.
  • GIP agonist → potentiates insulin secretion and supports fat-tissue metabolism.
  • Glucagon agonist → increases hepatic glucose output and thermogenesis, contributing to overall energy expenditure.

Research Highlights:
Triple receptor co-agonism produces superior metabolic outcomes compared to single or dual agonists. Studies demonstrate significant reductions in body weight, improved insulin sensitivity, and favorable lipid profile changes.